Ligandrol is a novel nonsteroidal oral selective androgen receptor modulator for treatment of conditions such as muscle wasting and osteoporosis, discovered by Ligand Pharmaceuticals and under development by Viking Therapeutics. Reference standards of Ligandrol API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Ligandrol - API Standards [catalogue_number] => PA 65 26000 [category_ids] => ,70,75,76,78,82, [chemical_name] => [weight] => 351.29 [form] => C16H15F6NO [cas] => 1165910-22-4 [pslug] => 1165910-22-4-ligandrol-api-pa6526000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 65 26000
CAS :
Molecular Formula : C16H15F6NO
Molecular Weight : 351.29
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
